TRI TrivarX Limited
Healthcare · Health Information Services
· website
$0.01
52wk 0.01 – 0.04
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About TrivarX Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$17.31M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.84
EV / EBITDA
-7.03
Price / Book
0.75
ROE
-12.1%
Operating margin
-55,089.1%
Net margin
0.0%
Total cash
$3.47M
Total debt
$148,818
Current ratio
5.45
Debt / Equity
0.01
Free cash flow
$-3.06M
Avg volume
1.09M
Latest annual results
(FY ending 30 Jun 2024)
- Revenue—
- Gross profit—
- Operating income-$2.31M
- Net income-$1.24M
- Diluted EPS-0.00
- Free cash flow-$3.98M
- Net debt-$832.20K